Chronic kidney disease stage progression in liver transplant recipients

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 8, 2011, Pages 1851-1857

  LaMattina, John C ^a   Foley, David P ^a   Mezrich, Joshua D ^a   Fernandez, Luis A ^a   Vidyasagar, Vijay ^a   D'Alessandro, Anthony M ^a   Musat, Alexandru I ^a   Samaniego Picota, Milagros D ^b   Pascual, Julio ^c   Alejandro, Munoz D R ^a   Leverson, Glen E ^a   Pirsch, John D ^a   Djamali, Arjang ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HYPERCHOLESTEROLEMIA; KAPLAN MEIER METHOD; KIDNEY FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; OUTCOME ASSESSMENT; PROPORTIONAL HAZARDS MODEL; REVIEW; RISK FACTOR; SURVIVAL RATE; URINARY TRACT INFECTION;

ADULT; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT SURVIVAL; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; KIDNEY; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; WISCONSIN;

EID: 80051557138     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00650111     Document Type: Review

References (24)

1. Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK: Long-term survival in renal transplant recipients with graft function. Kidney Int 57: 307-313, 2000
2. Fisher NC, Nightingale PG, Gunson BK, Lipkin GW, Neuberger JM: Chronic renal failure following liver transplantation: A retrospective analysis. Transplantation 66: 59-66, 1998
3. Schmitz V, Laudi S, Moeckel F, Puhl G, Stockmann M, Tran ZV, Kahl A, Neumann U, Neuhaus P: Chronic renal dysfunction following liver transplantation. Clin Transplant 22: 333-340, 2008
4. Gonwa TA, Mai ML, Melton LB, Hays SR, Goldstein RM, Levy MF, Klintmalm GB: End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurinbased immunotherapy: Risk of development and treatment. Transplantation 72: 1934-1939, 2001
5. Sabry AA, Sobh MA, Irving WL, Grabowska A, Wagner BE, Fox S, Kudesia G, El Nahas AM: A comprehensive study of the association between hepatitis C virus and glomerulopathy. Nephrol Dial Transplant 17: 239-245, 2002
6. Amore A, Coppo R, Roccatello D, Piccoli G, Mazzucco G, Gomez-Chiarri M, Lamm ME, Emancipator SN: Experimental IgA nephropathy secondary to hepatocellular injury induced by dietary deficiencies and heavy alcohol intake. Lab Invest 70: 68-77, 1994
7. Weir MR, Fink JC: Risk for posttransplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis 34: 1-13, 1999
8. Newell GC: Cirrhotic glomerulonephritis: Incidence, morphology, clinical features, and pathogenesis. Am J Kidney Dis 9: 183-190, 1987
9. Velidedeoglu E, Bloom RD, Crawford MD, Desai NM, Campos L, Abt PL, Markmann JW, Mange KC, Olthoff KM, Shaked A, Markmann JF: Early kidney dysfunction post liver transplantation predicts late chronic kidney disease. Transplantation 77: 553-556, 2004
10. Kasiske BL: Hyperlipidemia in patients with chronic renal disease. Am J Kidney Dis 32: S142-S156, 1998
11. Sehgal AR, Snow RJ, Singer ME, Amini SB, DeOreo PB, Silver MR, Cebul RD: Barriers to adequate delivery of hemodialysis. Am J Kidney Dis 31: 593-601, 1998
12. Platz KP, Mueller AR, Blumhardt G, Bachmann S, Bechstein WO, Kahl A, Neuhaus P: Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506. Transplantation 58: 170-178, 1994
13. Iwatsuki S, Esquivel CO, Klintmalm GB, Gordon RD, Shaw BW Jr., Starzl TE: Nephrotoxicity of cyclosporine in liver transplantation. Transplant Proc 17: 191-195, 1985
14. A comparison of tacrolimus (FK 506), cyclosporine for immunosuppression in liver transplantation. The US: Multicenter FK506 Liver Study Group. N Engl J Med 331: 1110-1115, 1994
15. Bennett WM, DeMattos A, Meyer MM, Andoh T, Barry JM: Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy. Kidney Int 50: 1089-1100, 1996
16. Olyaei AJ, de Mattos AM, Bennett WM: Nephrotoxicity of immunosuppressive drugs: New insight and preventive strategies. Curr Opin Crit Care 7: 384-389, 2001
17. Burdmann EA, Andoh TF, Yu L, Bennett WM: Cyclosporine nephrotoxicity. Semin Nephrol 23: 465-476, 2003
18. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D: Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342: 605-612, 2000
19. Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP: Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 62: 311-318, 2002
20. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341: 1725-1730, 1999
21. Cecka JM: The UNOS Scientific Renal Transplant Registry. Clin Transpl 1-16, 1998
22. Shoskes DA, Cecka JM: Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation 66: 1697-1701, 1998
23. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
24. Djamali A, Kendziorski C, Brazy PC, Becker BN: Disease progression and outcomes in chronic kidney disease and renal transplantation. Kidney Int 64: 1800-1807, 2003